The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, according to a new study. These data provide evidence that may help to...
View our extensive library of over 2,000 articles for vital mental health and substance use disorder education, information, support, advocacy, and quality resources
Reach an Engaged Behavioral Health Audience
Connect with 30,000+ average monthly users and 420,000 annual pageviews across a trusted platform serving professionals, families, and individuals in the mental health and substance use disorder communities.
BHN Summer 2026 Issue
“The Role of Policy and Advocacy in Shaping Behavioral Health Care Systems"
